UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

S2348 Exposure-Response Analysis of Open Label Tradipitant in Idiopathic and Diabetic Gastroparesis in Study VP-VLY-686-3301

The American journal of gastroenterology, 2024-10, Vol.119 (10S), p.S1682-S1682

2024

Volltextzugriff (PDF)

S2347 Open Label Efficacy Analysis of Tradipitant in Idiopathic and Diabetic Gastroparesis

The American journal of gastroenterology, 2024-10, Vol.119 (10S), p.S1681-S1682

2024

Volltextzugriff (PDF)

S1900 Open Label Efficacy Analysis of Tradipitant in Idiopathic and Diabetic Gastroparesis

The American journal of gastroenterology, 2023-10, Vol.118 (10S), p.S1411-S1411

2023

Volltextzugriff (PDF)

An observational study investigating the CRY1Δ11 variant associated with delayed sleep–wake patterns and circadian metabolic output

Scientific reports, 2021-10, Vol.11 (1), p.20103-20103, Article 20103

2021

Volltextzugriff (PDF)

S1592 Efficacy Analysis of Tradipitant in Idiopathic and Diabetic Gastroparesis in Study VP-VLY-686-3301

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e1135-e1136

2022

Volltextzugriff (PDF)

S1588 Pooled Efficacy Analysis of Tradipitant in Idiopathic and Diabetic Gastroparesis Study VP-VLY-686-3301 and VP-VLY-686-2301

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e1133-e1133

2022

Volltextzugriff (PDF)

Clock bias prediction algorithm for navigation satellites based on a supervised learning long short-term memory neural network

GPS solutions, 2021-04, Vol.25 (2), Article 80

2021

Volltextzugriff (PDF)

S1420 Tradipitant, a Novel Neurokinin-1 Receptor Antagonist, Showed Continued Improvement in Nausea and Other Symptoms Associated with Gastroparesis in an Open-Label Extension of a Phase II Clinical Trial

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S651-S651

2021

Volltextzugriff (PDF)

Tasimelteon for non-24-hour sleep–wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials

The Lancet (British edition), 2015-10, Vol.386 (10005), p.1754-1764

2015

Volltextzugriff (PDF)

Validation of the motion sickness severity scale: Secondary analysis of a randomized, double-blind, placebo-controlled study of a treatment for motion sickness

PloS one, 2023-01, Vol.18 (1), p.e0280058-e0280058

2023

Volltextzugriff (PDF)

Tasimelteon safely and effectively improves sleep in Smith–Magenis syndrome: a double-blind randomized trial followed by an open-label extension

Genetics in medicine, 2021-12, Vol.23 (12), p.2426-2432

2021

Volltextzugriff (PDF)

Loss-of-function mutations in IFNAR2 in COVID-19 severe infection susceptibility

Journal of global antimicrobial resistance., 2021-09, Vol.26, p.239-240

2021

Volltextzugriff (PDF)

Genomic and phenotypic characterization of Investigator Global Assessment (IGA) scale-based endotypes in atopic dermatitis

Journal of the American Academy of Dermatology, 2021-12, Vol.85 (6), p.1638-1640

2021

Volltextzugriff (PDF)

Estimating Burden of Disease Among Blind Individuals With Non-24-Hour Sleep-Wake Disorder

Frontiers in neurology, 2021-01, Vol.11, p.605240-605240

2021

Volltextzugriff (PDF)

Corrigendum: Case report: A patient with Delayed Sleep-Wake Phase Disorder and Optic Nerve Hypoplasia treated with tasimelteon: a case study

Frontiers in neuroscience, 2024-01, Vol.17, p.1344915-1344915

2024

Volltextzugriff (PDF)

Case report: A patient with Delayed Sleep-Wake Phase Disorder and Optic Nerve Hypoplasia treated with tasimelteon: a case study

Frontiers in neuroscience, 2023-11, Vol.17, p.1287514

2023

Volltextzugriff (PDF)

Once-daily tasimelteon (VEC-162) for jet lag following transmeridian travel: A multicenter, randomized, double-blind, placebo-controlled trial

Frontiers in neurology, 2022-09, Vol.13, p.901467-901467

2022

Volltextzugriff (PDF)

Enrichment of Motilin Receptor Loss-of-Function Variants in Gastroparesis

Clinical and translational gastroenterology, 2022-04, Vol.13 (4), p.e00474-e00474

2022

Volltextzugriff (PDF)

Tradipitant in the Treatment of Motion Sickness: A Randomized, Double-Blind, Placebo-Controlled Study

Frontiers in neurology, 2020-09, Vol.11

2020

Volltextzugriff (PDF)

Efficacy of Tasimelteon (HETLIOZ®) in the Treatment of Jet Lag Disorder Evaluated in an 8-h Phase Advance Model; a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Frontiers in neurology, 2020-07, Vol.11

2020

Volltextzugriff (PDF)

44217 Itch and Sleep Improvements in a Pooled Analysis of Neurokinin-1 Receptor Antagonist Tradipitant in Atopic Dermatitis

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB184-AB184

2023

Volltextzugriff (PDF)

Su1634 A BASELINE SEVERITY INFLATION ANALYSIS IN STUDY VP-VLY-686-3301 OF TRADIPITANT IN GASTROPARESIS

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-630-S-630

2023

Volltextzugriff (PDF)

0642 Effect of Iloperidone on Sleep Symptoms in Bipolar Patients with Manic and Mixed Episodes: A Randomized, Placebo Controlled Study

Sleep (New York, N.Y.), 2023-05, Vol.46 (Supplement_1), p.A282-A282

2023

Volltextzugriff (PDF)

Mo1639 OPEN LABEL EFFICACY ANALYSIS OF TRADIPITANT IN IDIOPATHIC AND DIABETIC GASTROPARESIS

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1067-S-1067

2024

Volltextzugriff (PDF)

Su1632 EFFICACY ANALYSIS OF TRADIPITANT IN IDIOPATHIC AND DIABETIC GASTROPARESIS IN STUDY VP-VLY-686-3301

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-629-S-629

2023

Volltextzugriff (PDF)

1 – 25 von 151

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(130)
Mit Volltextzugriff
(130)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(84)
Life Sciences & Biomedicine
(58)
Humans
(17)
Technology
(17)
Physical Sciences
(15)
Nausea
(11)
Diabetes
(10)
Environmental Sciences
(10)
Environmental Sciences & Ecology
(10)
Male
(10)
Animals
(9)
Engineering
(9)
Materials Science
(9)
Materials Science, Multidisciplinary
(9)
Pharmacology & Pharmacy
(8)
Sleep
(8)
Physics
(7)
Proteins
(7)
Mice
(6)
Neurosciences
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

S2348 Exposure-Response Analysis of Open Label Tradipitant in Idiopathic and Diabetic Gastroparesis in Study VP-VLY-686-3301

S2347 Open Label Efficacy Analysis of Tradipitant in Idiopathic and Diabetic Gastroparesis

S1900 Open Label Efficacy Analysis of Tradipitant in Idiopathic and Diabetic Gastroparesis

An observational study investigating the CRY1Δ11 variant associated with delayed sleep–wake patterns and circadian metabolic output

S1592 Efficacy Analysis of Tradipitant in Idiopathic and Diabetic Gastroparesis in Study VP-VLY-686-3301

S1588 Pooled Efficacy Analysis of Tradipitant in Idiopathic and Diabetic Gastroparesis Study VP-VLY-686-3301 and VP-VLY-686-2301

Clock bias prediction algorithm for navigation satellites based on a supervised learning long short-term memory neural network

S1420 Tradipitant, a Novel Neurokinin-1 Receptor Antagonist, Showed Continued Improvement in Nausea and Other Symptoms Associated with Gastroparesis in an Open-Label Extension of a Phase II Clinical Trial

Tasimelteon for non-24-hour sleep–wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials

Validation of the motion sickness severity scale: Secondary analysis of a randomized, double-blind, placebo-controlled study of a treatment for motion sickness

Tasimelteon safely and effectively improves sleep in Smith–Magenis syndrome: a double-blind randomized trial followed by an open-label extension

Loss-of-function mutations in IFNAR2 in COVID-19 severe infection susceptibility

Genomic and phenotypic characterization of Investigator Global Assessment (IGA) scale-based endotypes in atopic dermatitis

Estimating Burden of Disease Among Blind Individuals With Non-24-Hour Sleep-Wake Disorder

Corrigendum: Case report: A patient with Delayed Sleep-Wake Phase Disorder and Optic Nerve Hypoplasia treated with tasimelteon: a case study

Case report: A patient with Delayed Sleep-Wake Phase Disorder and Optic Nerve Hypoplasia treated with tasimelteon: a case study

Once-daily tasimelteon (VEC-162) for jet lag following transmeridian travel: A multicenter, randomized, double-blind, placebo-controlled trial

Enrichment of Motilin Receptor Loss-of-Function Variants in Gastroparesis

Tradipitant in the Treatment of Motion Sickness: A Randomized, Double-Blind, Placebo-Controlled Study

Efficacy of Tasimelteon (HETLIOZ®) in the Treatment of Jet Lag Disorder Evaluated in an 8-h Phase Advance Model; a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

44217 Itch and Sleep Improvements in a Pooled Analysis of Neurokinin-1 Receptor Antagonist Tradipitant in Atopic Dermatitis

Su1634 A BASELINE SEVERITY INFLATION ANALYSIS IN STUDY VP-VLY-686-3301 OF TRADIPITANT IN GASTROPARESIS

0642 Effect of Iloperidone on Sleep Symptoms in Bipolar Patients with Manic and Mixed Episodes: A Randomized, Placebo Controlled Study

Mo1639 OPEN LABEL EFFICACY ANALYSIS OF TRADIPITANT IN IDIOPATHIC AND DIABETIC GASTROPARESIS

Su1632 EFFICACY ANALYSIS OF TRADIPITANT IN IDIOPATHIC AND DIABETIC GASTROPARESIS IN STUDY VP-VLY-686-3301

Suchergebnisse filtern